KYMR Q2 Earnings and Revenues Top Estimates on Gilead, Sanofi Payments
Kymera Therapeutics, Inc. KYMR reported a second-quarter 2026 loss of 62 cents per share, narrower than the Zacks…
Sanofi Beats on Q2 Earnings & Sales, Stock Down on Pipeline Setbacks
Sanofi SNY reported second-quarter 2026 adjusted earnings of $1.22 per American depositary share, which comfortably beat the Zacks…